Related Documents
-
Notice: Human drugs:
New drug applications— Penthrane (methoxyflurane) Inhalation Liquid, 99.9 percent; approval withdrawn
98 reads -
Notice: Meetings: Substance Abuse Treatment Center National Advisory Council
17 reads -
Notice: Human drugs:
New drug applications— Industry Exchange Workshop on Food and Drug Administration Clinical Trial Requirements
48 reads -
Notice: Committees; establishment, renewal, termination, etc.: CollaGenex Pharmaceuticals, Inc., approval withdrawn
71 reads -
Notice: Human drugs:
Drug products withdrawn from sale for reasons other than safety or effectiveness— ACIPHEX (rabeprazol sodium)
73 reads -
Notice: Human drugs:
Drug products withdrawn from sale for reasons other than safety or effectiveness— SURPASS
48 reads -
Notice: Human drugs:
Drug products withdrawn from sale for reasons other than safety or effectiveness— Animal Drug User Fee Act; performance and reauthorization
37 reads -
Notice: Meetings: Oncologic Drugs Advisory Committee; correction
45 reads -
Notice: Meetings: Prescription Drug User Fee Act; correction
37 reads -
Notice: Harmonisation International Conference; guidelines availability: Biotechnological/biological products; Q5E comparability subject to changes in manufacturing process
80 reads -
Notice: Meetings: Psychopharmacologic Drugs Advisory Committee
41 reads -
Notice: Meetings: Houston/Galveston Navigation Safety Advisory Committee
40 reads -
Notice: Human drugs:
Best Pharmaceuticals for Children Act— Pediatric studies; INVANZ , KEPPRA, TRILEPTAL, and ZYVOX; medical and clinical pharmacology review summaries; availability
243 reads -
Notice: Grants and cooperative agreements; availability, etc.: Deputy Assistant Secretary for Administration and Management
38 reads -
Notice: Committees; establishment, renewal, termination, etc.: Medical Devices Advisory Committee
36 reads -
Notice: Committees; establishment, renewal, termination, etc.: Medical Devices Advisory Committee
24 reads -
Notice: Human drugs:
New drug applications— High Chemical Co., et al. approval withdrawn
34 reads -
Notice: Human drugs:
New drug applications— Psychopharmaceutical Drugs Advisory Committee
82 reads -
Notice: Meetings: Houston/Galveston Navigation Safety Advisory Committee
29 reads -
Notice: Harmonisation International Conference; guidelines availability: Blood Products Advisory Committee
40 reads
Related Documents
Flag this document
2 Pages
